CDT CDT
Company Profile ↓Company Overview
CDT (CDT) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.01.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -99.05% |
| 6 Months: | -89.20% |
| 3 Months: | +72.60% |
| 1 Month: | +715.91% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)70.22 · Overbought
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 99.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -4.38K | -263.72K | -279.42K | -933.00K | -1.51M | -1.31M | -430.00K | -2.96M | -3.14M | -5.81M | -3.62M | -4.95M | -7.03M | -3.66M |
| Net Income | -4.38K | -253.54K | -117.54K | -956.00K | -1.67M | -2.11M | 2.62M | -3.55M | -5.38M | -6.46M | -4.75M | -6.03M | -7.12M | -4.06M |
| Diluted EPS | - | - | - | -0.03 | -0.03 | -0.03 | 0.01 | -4.81 | -109.33 | -889.58 | -3,670.27 | -5.46 | -13.16 | -5.56 |
| R&D Expense | - | - | - | 38.00K | - | - | - | 128.00K | 25.00K | 3.09M | 916.00K | 1.86M | 1.53M | 778.00K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Income | -3.16M | -5.26M | -15.42M | -36.76M |
| Net Income | -4.89M | -535.00K | -17.80M | -39.22M |
| Diluted EPS | -0.13 | -8.92 | -61,598.62 | -1,177.89 |
| R&D Expense | 37.00K | 90.00K | 3.38M | 5.05M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Mar 2023 | Jun 2023 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | 213.12K | 5.00K | 506.00K | 900.00K | 7.22M | 4.19M | 5.65M |
| Total Equity | -5.96M | -10.09M | -12.02M | -14.51M | -457.00K | -6.79M | -7.17M |
| Cash & Equivalents | 48.55K | 345.78K | - | - | 4.23M | 554.00K | 1.51M |
| Total Liabilities | 192.51K | 10.09M | - | - | 7.68M | 10.99M | 12.82M |
| Current Liabilities | 192.51K | 4.18M | - | - | 1.80M | 10.74M | 12.82M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -2.27M | -7.72M | -9.68M | -15.55M |
| Investing Cash Flow | -183.00K | 725.00K | -43.00K | -808.00K |
| Financing Cash Flow | 2.45M | 10.93M | 6.07M | 17.42M |
| Capital Expenditure | - | - | -51.00K | - |
| Free Cash Flow | - | - | -9.73M | - |
| Share Buybacks | - | - | - | 106.00K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | - |
| Net Margin % | - | - | - | - |
| ROE % | 48.4% | 117.1% | 262.1% | 547.1% |
| ROCE % | 75.8% | -97.0% | 235.5% | 512.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CDT
Sarborg Launches Quantum Division From Pharmaceuticals to Sugarcane - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQaldFTlJOU1hxa29vSHJhNkN4cGp0YjA0WkpXaml0TU53Mm5STDgybnc4QTJScEJITWV5UEhNVmdlLXVibHJocmFHc0RnTVdPSm1SQWV6aWdIQ2xNeFdfTHV6dG00b3QyM2RHdjJEeVBwUVNUQ2pxdlBTOWhaS0Q3WVgzaFRqM2tkSnc2TW…
CDT Equity Inc. Announces Reverse Stock Split - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOZ2cwMjQ1SzYxV2xnMGpna25XaDdINTN5TGhKa2cxT085d2gtUWRuOEJyVVVmNk82dkpWUTU0dDZON3BtN2NMNXRzQTV2Yk8yX0pmYTRHQklOWnptTmhfQmRfdjBvSFVrdVhYdE1hbmxpX1hWMXJyR3JPcmY3T3VKUnhQYVlZNVVDUWo1RG…
CDT Equity Inc. Revenue Breakdown – NASDAQ:CDT - TradingView
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE9DTnA4SC1xVHhzRjNDek9GRTc0VlRzOTZsV0hoZ0ZLM0ZFemhJZXBtZFFmbC1CQUFHbmNhSm1CM0NWb0xuWEx6djdGSXAxcEhYWDRIUTloSzJWVms0aFdQUHpiSklZQXBjWktodVBIRWE1dXpzN3c?oc=5" target="_blank">CDT Equi…
CDT Equity Company Profile & Introduction - Moomoo
<a href="https://news.google.com/rss/articles/CBMioAJBVV95cUxOUDdOdmxhS3ZITmN5aHJVRWtpZElxcnBkd3RYLWlnM0hZV1FtRFZCTVlMWXVERGVkT1hrUlA4SDA2RDZuaVFhbVp5c3JsX3dmdmNZdm04aVJwanhIVFUtQnV1aXhWWGdUeHlyNFVoQ01TQ2d3emJSYW0zenlpTDdldHAxbDcxNjZWNEpxQV…
CDT Equity (CDT) 10K Form and Latest SEC Filings 2026 - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE0yTDRsbmI1cTFRMFBBSVpJMjhsRlR5TFBnaHBHYVIyMW95RjNVR29CdV80eVl2dHF0TEhoVHcxblRhbmhvVUJJWnBCTkJCSDYzdmE5cm1ab2dHbkgtWi1pN1RPQmkzOHF3?oc=5" target="_blank">CDT Equity (CDT) 10K Form a…
CDT jumps after Sarborg funding update spotlights value of CDT’s stake - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQc3VzeWRsZnNBNDZJOTlIWkFxNy1QTVNhRDZzMksxLThHczd4cFRxQm8xa3JRVzRqRjlMYXVsc1NXLWRHaXhOeW05aDczNnl5b01zUXcxN1NtS0dta3ZNcWlTX3c2bUU2VEhZYlNTVXE5ejNjLW1XXzA2RDVnWjVNbGtUZk9DZXRoR2RZY0…
CDT — Frequently Asked Questions
What is the current share price of CDT?
As of 2026-08-05 17:25 PDT, CDT trades at $3.59 on NASDAQ/NYSE. Its 52-week range is $0.31 to $378.00.
Is CDT a good stock to buy?
This page provides a data-driven analysis of CDT, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.